Bio/Pharma Business

VeriSIM Life and Mayo Clinic Team Up to Co-develop New Therapies

July 08, 2022

VeriSIM Life and Mayo Clinic are collaborating to develop new promising drug candidates.

NRG Therapeutics and Domainex Partner on Parkinson’s Disease Drug Development Project

July 08, 2022

NRG Therapeutics and Domainex aim to develop novel small-molecule drugs to treat neurodegenerative disorders, such as Parkinson’s disease.

LG Chem Renews License with Avacta for IND Studies

July 08, 2022

LG Chem has decided to proceed with IND-enabling studies and has renewed a license with Avacta.

Trends in International Arbitration: The Fallout from COVID-19

July 02, 2022

As a result of the disruptions caused by the COVID-19 pandemic, global arbitration has adapted to a ‘new normal’.

What is Wrong with the Neuroscience Drug Market?

July 02, 2022

Pharma should expand on successful cell therapies in oncology by applying these development and manufacturing methods to neuronal cell therapies.

Ipsen Expands Oncology Portfolio with $247 Million Epizyme Acquisition

June 30, 2022

Ipsen will acquire Epizyme, who recently had their lead medicine Tazverik (tazemetostat) approved by FDA for treatment of relapsed or refractory follicular lymphoma.

ImmunoGen Partners with Oxford BioTherapeutics to Develop Novel ADCs

June 27, 2022

ImmunoGen has formed a research collaboration with Oxford BioTherapeutics to develop novel antibody-drug conjugates for cancers with high unmet needs.

Kindeva Drug Delivery Completes Acquisition of iPharma Labs

June 22, 2022

Kindeva’s acquisition of iPharma will increase the company’s inhalation formulation outsourcing capabilities.

Aptamer Group Signs Deal with Flip Gene Therapeutics

June 17, 2022

Aptamer Group has signed a deal with Flip Gene Therapeutics to support the development of inducible gene therapies.

Boehringer Ingelheim to Acquire Trutino Biosciences

June 17, 2022

Boehringer Ingelheim has signed an option to acquire Trutino Biosciences.